This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Breast cancer is the leading cancer diagnosed in women in the United States, with an estimated 176,300 new cases in 1999. The broad long-term objectives are to determine if gene therapy via intratumoral delivery of adenoviral vectors expressing immunomodulatory genes can be safely tolerated and be effective in producing tumor regression and antitumor imunity in patients with metastatic breast cancer. One of the goals of this study is to investigate if the tumor in the patient's liver can be genetically changed so that it produces a substance called interleukin-12. This treatment is called gene therapy.
Showing the most recent 10 out of 869 publications